Glenmark Life Sciences Limited (GLS.BO)
INR 1021.7
(-0.42%)
INR 1021.7
(-0.42%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 12.43 Billion INR | 26.04% |
| 2022 | 10.16 Billion INR | -1.29% |
| 2021 | 10.29 Billion INR | 8.89% |
| 2020 | 9.45 Billion INR | 19.45% |
| 2019 | 7.91 Billion INR | 8.16% |
| 2018 | 7.32 Billion INR | 6654518.18% |
| 2017 | 110 Thousand INR | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q2 | 2.81 Billion INR | -11.08% |
| 2024 Q1 | 2.29 Billion INR | -22.93% |
| 2023 Q1 | 3.3 Billion INR | 57.11% |
| 2023 FY | 12.81 Billion INR | 26.04% |
| 2023 Q3 | 3.3 Billion INR | 2.58% |
| 2023 Q2 | 3.22 Billion INR | -2.46% |
| 2023 Q4 | 2.97 Billion INR | -9.89% |
| 2022 Q1 | 2.6 Billion INR | 25.25% |
| 2022 FY | 10.16 Billion INR | -1.29% |
| 2022 Q4 | 2.1 Billion INR | -23.77% |
| 2022 Q3 | 2.75 Billion INR | 2.44% |
| 2022 Q2 | 2.69 Billion INR | 3.2% |
| 2021 Q1 | 2.65 Billion INR | 10.3% |
| 2021 Q2 | 2.9 Billion INR | 9.42% |
| 2021 Q3 | 2.65 Billion INR | -8.68% |
| 2021 Q4 | 2.08 Billion INR | -21.47% |
| 2021 FY | 10.29 Billion INR | 8.89% |
| 2020 FY | 9.45 Billion INR | 19.45% |
| 2020 Q4 | 2.4 Billion INR | -6.19% |
| 2020 Q3 | 2.56 Billion INR | 13.13% |
| 2020 Q2 | 2.26 Billion INR | 2.39% |
| 2020 Q1 | 2.21 Billion INR | 0.0% |
| 2019 FY | 7.91 Billion INR | 8.16% |
| 2018 FY | 7.32 Billion INR | 6654518.18% |
| 2017 FY | 110 Thousand INR | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Ajanta Pharma Limited | 21.06 Billion INR | 40.975% |
| Amrutanjan Health Care Limited | 1.55 Billion INR | -698.762% |
| Sigachi Industries Limited | 2 Billion INR | -520.941% |
| Bal Pharma Limited | 770.19 Million INR | -1514.265% |
| Ind-Swift Laboratories Limited | 6.19 Billion INR | -100.715% |
| Medico Remedies Limited | 262.14 Million INR | -4642.809% |
| Lasa Supergenerics Limited | 121.02 Million INR | -10172.651% |
| Venus Remedies Limited | 2.18 Billion INR | -469.645% |
| Sun Pharma Advanced Research Company Limited | -602.4 Million INR | 2163.889% |
| Alpa Laboratories Limited | 188.89 Million INR | -6481.958% |
| Nectar Lifesciences Limited | 2.97 Billion INR | -318.329% |
| Shilpa Medicare Limited | 3.54 Billion INR | -250.535% |
| Aarti Drugs Limited | 8.31 Billion INR | -49.503% |
| Lupin Limited | 123.71 Billion INR | 89.951% |
| Aurobindo Pharma Limited | 154.68 Billion INR | 91.962% |
| Zydus Lifesciences Limited | 125.21 Billion INR | 90.07% |
| Windlas Biotech Limited | 1.33 Billion INR | -828.667% |
| Suven Life Sciences Limited | -200.79 Million INR | 6291.821% |
| Eris Lifesciences Limited | 10.42 Billion INR | -19.241% |
| Valiant Laboratories Limited | -60.66 Million INR | 20594.84% |
| J. B. Chemicals & Pharmaceuticals Limited | 22.69 Billion INR | 45.229% |
| Solara Active Pharma Sciences Limited | 861.2 Million INR | -1343.682% |
| Ipca Laboratories Limited | 29.8 Billion INR | 58.292% |
| Bliss GVS Pharma Limited | 3.69 Billion INR | -236.442% |
| Achyut Healthcare Limited | 4.86 Million INR | -255670.212% |
| Sun Pharmaceutical Industries Limited | 258.48 Billion INR | 95.19% |
| Bajaj HealthCare Limited | 1.47 Billion INR | -744.744% |
| RPG Life Sciences Limited | 2.48 Billion INR | -400.725% |
| Mankind Pharma Limited | 44.52 Billion INR | 72.074% |
| Laurus Labs Limited | 24.62 Billion INR | 49.501% |
| Piramal Pharma Limited | 24.47 Billion INR | 49.193% |
| Syncom Formulations (India) Limited | 942.39 Million INR | -1219.292% |
| Torrent Pharmaceuticals Limited | 46.75 Billion INR | 73.41% |
| Alembic Pharmaceuticals Limited | 26.78 Billion INR | 53.575% |
| Glenmark Pharmaceuticals Limited | 69.34 Billion INR | 82.07% |
| Unichem Laboratories Limited | 4.86 Billion INR | -155.564% |
| Sequent Scientific Limited | 2.97 Billion INR | -317.392% |
| Novartis India Limited | 1.32 Billion INR | -836.995% |
| Wanbury Limited | 1.73 Billion INR | -618.403% |
| Suven Pharmaceuticals Limited | 4.12 Billion INR | -201.532% |
| Wockhardt Limited | 16.24 Billion INR | 23.442% |
| Themis Medicare Limited | 1.5 Billion INR | -726.714% |
| Jagsonpal Pharmaceuticals Limited | 652.59 Million INR | -1805.176% |
| Jubilant Pharmova Limited | 19.64 Billion INR | 36.705% |
| Dr. Reddy's Laboratories Limited | 163.6 Billion INR | 92.401% |
| Divi's Laboratories Limited | 32.44 Billion INR | 61.674% |
| NATCO Pharma Limited | 25.73 Billion INR | 51.69% |
| Gufic Biosciences Limited | 4.16 Billion INR | -198.317% |
| IOL Chemicals and Pharmaceuticals Limited | 4.58 Billion INR | -171.415% |
| Ind-Swift Limited | 2.17 Billion INR | -472.281% |
| Procter & Gamble Health Limited | 5.78 Billion INR | -115.052% |
| FDC Limited | 8.33 Billion INR | -49.171% |
| Krebs Biochemicals & Industries Limited | 192.72 Million INR | -6351.089% |
| Granules India Limited | 16.79 Billion INR | 25.991% |
| Medicamen Biotech Limited | 495.49 Million INR | -2409.206% |
| Alkem Laboratories Limited | 52.29 Billion INR | 76.226% |
| AstraZeneca Pharma India Limited | 6.22 Billion INR | -99.801% |
| Biofil Chemicals and Pharmaceuticals Limited | 14.57 Million INR | -85176.034% |
| Brooks Laboratories Limited | 65.62 Million INR | -18846.952% |
| Megasoft Limited | 342.07 Million INR | -3534.623% |
| ZIM Laboratories Limited | 1.26 Billion INR | -881.381% |
| Strides Pharma Science Limited | 14.38 Billion INR | 13.588% |
| Neuland Laboratories Limited | 8.24 Billion INR | -50.742% |
| Morepen Laboratories Limited | 6.16 Billion INR | -101.792% |
| Hikal Limited | 3.14 Billion INR | -295.567% |
| Indoco Remedies Limited | 6.04 Billion INR | -105.799% |
| Aarti Pharmalabs Limited | 5.83 Billion INR | -113.209% |
| Kilitch Drugs (India) Limited | 620.47 Million INR | -1903.779% |
| Mangalam Drugs & Organics Limited | 703.6 Million INR | -1667.041% |
| Hester Biosciences Limited | 1.27 Billion INR | -876.17% |